The first Covid-19 patient was confirmed in India on January 30, 2020. In the last three years, India saw nationwide lockdowns, mass exodus from cities and a devastating Delta wave. What stood out amid all the gloom were acts of kindness by absolute strangers and the successful vaccination drive. Here's the story of India's Covid fightback.
DCGI noted that Covavax is a technology transfer of Novovax vaccine and sought approval status of the application with regulatory authorities in origin country.
Covishield maker SII seeks indemnity from liability
Covishield maker SII seeks indemnity from liability
IANS / Updated: Jun 4, 2021, 09:06 IST
#NEWDELHI Pune-based Serum Institute of India (SII), which manufactures
Covishield, has also sought indemnity from liability, expressing the hope that rules would be the same for everyone, said sources. This comes as the Centre is favourably considering granting indemnity against legal proceedings to foreign vaccine makers Pfizer and Moderna prior to their rollout in India.
“All vaccine makers, whether Indian or foreign, should be granted the same protection,” the Adar Poonawalla-led company has reportedly told the government.
“Not just Serum Institute of India (SII), all the vaccine companies should get indemnity protection against liabilities if foreign companies are granted it,” it further said. It is learnt that Serum is hoping that rules should be same for everyone. The Serum Institute produces Covishield (the Indian name f